KSK-120 is a potent Chlamydia trachomatis inhibitor that targets the glucose metabolism pathway of Chlamydia trachomatis. KSK120 targets the glucose-6-phosphate (G-6P) metabolism pathway of C. trachomatis, supporting previous indications that G-6P metabolism is critical for C. trachomatis infectivity. Thus, KSK120 may be a useful tool to study chlamydial glucose metabolism and has the potential to be used in the treatment of C. trachomatis infections. References: Engstrom P, Bergstrom M, Alfaro AC, Syam Krishnan K, Bahnan W, Almqvist F, Bergstrom S. Expansion of the Chlamydia trachomatis inclusion does not require bacterial replication. Int J Med Microbiol. 2015 May;305(3):378-82. doi: 10.1016/j.ijmm.2015.02.007. Epub 2015 Feb 27. PubMed PMID: 25771502.

纯度：≥98%

CAS：1638100-63-6